40 likes | 53 Views
Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
E N D
Orion Market Research Imatinib Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026
Request a Free Sample @ https://www.omrglobal.com/request-sample/imatinib-drug- market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404 The global imatinib drug market is estimated to grow at a CAGR of around 4% during the forecast period. The major factors contributing to the growth of the market include the rising prevalence of cancer and an increase in awareness programs towards cancer by government and private organizations. Imatinib is a chemotherapy drug that used to slow down or stopping the growth of the cancer cells. This medication is used for the treatment of certain types of cancer including, acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic syndrome. Imatinib drug helps in improving blood count which makes it highly effective and attracting the target patients for the adoption of this drug leading to the significant growth of the imatinib drug market. Get Free Sample Copy @https://www.omrglobal.com/request-sample/imatinib-drug-market Segmentation The global imatinib drug market is segmented based on drug form, and application. Based on drug form, the market is classified into tablets and capsules. Based on application the market is classified into blood cancer (leukemia and other blood cancers), gastrointestinal stromal tumors (GIST), skin tumors (dermatofibrosarcoma protuberans), and other tumors such as systemic mastocytosis. Blood cancer segment is expected to hold the major market share owing to increasing demand for imatinib for the treatment of different types of leukemia cancers such as Acute myeloid (or myelogenous) leukemia (AML), Chronic myeloid (or myelogenous) leukemia (CML), Acute lymphocytic (or lymphoblastic) leukemia (ALL), and Chronic lymphocytic leukemia (CLL).
Browse for Full Report Description@https://www.omrglobal.com/request-sample/imatinib- drug-market Market Segmentation Global Imatinib Drug Market by Drug Form Tablet Capsule Global Imatinib Drug Market by Application Blood Cancer (Leukemia and Other Blood Cancers) Gastrointestinal Stromal Tumors (GIST) Skin Tumors (Dermatofibrosarcoma Protuberans) Other Tumors (Systemic Mastocytosis) Regional Analysis North America United States Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific
China India Japan Rest of Asia-Pacific Rest of the World Company Profiles Apotex Inc. Cipla, Inc. Dr. Reddy’s Laboratory, Ltd. Glenmark Pharmaceutical, Ltd. Lupin, Ltd. Mylan N.V. Novartis AG Sun Pharmaceutical Industries, Ltd. Teva Pharmaceutical Industry, Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/imatinib-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404